共 25 条
[1]
Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, pp. 2893-2917, (2010)
[2]
Zhang H.Z., Jin G.F., Shen H.B., Epidemiologic differences in esophageal cancer between Asian and Western populations, Chin J Cancer, 312, pp. 81-86, (2012)
[3]
Ku G., Tan I.B., Yau T., Boku N., Laohavinij S., Cheng A.L., Kang Y.K., De Lima Lopes G., Management of colon cancer: Resource-stratified guidelines from the Asian Oncology Summit 2012, Lancet Oncol, 13, pp. e470-e481, (2012)
[4]
Yang W., Qi Q., Zhang H., Xu W., Chen Z., Wang L., Wang Y., Dong X., Jiao H., Huo Z., P21Waf1/Cip1 polymorphisms and risk of esophageal cancer, Ann Surg Oncol, 17, pp. 1453-1458, (2010)
[5]
El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Et al., WAF1, a potential mediator of p53 tumor supperssion, Cell, 75, pp. 817-825, (1993)
[6]
Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D., P21 is a universal inhibitor of cyclin kinases, Nature, 366, pp. 701-704, (1993)
[7]
Fotedar R., Bendjennat M., Fotedar A., Role of p21WAF1 in the cellular response to UV, Cell Cycle, 3, pp. 134-137, (2004)
[8]
Li G., Liu Z., Sturgis E.M., Shi Q., Chamberlain R.M., Spitz M.R., Et al., Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck, Carcinogenesis, 26, pp. 1596-1602, (2005)
[9]
Roninson I.B., Oncogenic functions of tumour suppressor p21 (Waf1/ Cip1/Sdi1): Association with cell senescence and tumour-promoting activities of stromal fibroblasts, Cancer Lett, 179, pp. 1-14, (2002)
[10]
Sun Y., Hildesheim A., Li H., Li Y., Chen J.Y., Cheng Y.J., Et al., No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): The polymorphism distinguishes Caucasians from Chinese, Cancer Epidemiol Biomarkers Prev, 4, pp. 261-267, (1995)